Background and aims Scar tissue accumulation in organs is the underlying cause of many
fibrotic diseases. Due to the extensive array of organs affected, the long-term nature of …

Sodium-glucose co-transporter 2 (SGLT2) inhibitors, originally used for diabetes mellitus,
are gaining more popularity for other indications, owing to their positive cardiovascular and …

Background: The impact of sodium-glucose cotransporter-2 inhibitors (SGLT2is) in addition
to optimal medical therapy (OMT) on the right ventricular (RV) systolic function using …

OBJECTIVE: In our study, we aimed at evaluating the change in biventricular functions and
pulmonary arterial stiffness (PAS) in patients with subclinical hypothyroidism (SH) in whom …

Purpose The aim of this study is to evaluate the safety of this drug in diabetic patients with
comorbidities of all systems. Method In this review, the beneficial effects of this drug and its …

Longstanding left-to-right shunting associated with congenital heart disease (CHD) can
ultimately lead to pulmonary vascular remodeling, pulmonary arterial hypertension, and …

Background: There is some discrepancy in current studies concerning the effect of sodium-
glucose cotransporter type 2 inhibitors (SGLT2i) on right ventricular (RV) functions in heart …

Background: The current global prevalence of heart failure is estimated at 64.34 million
cases and 9.91 million years of disability as a result. Heart failure remains one of the most …

Antecedentes: A pesar de la amplia investigación que se ha realizado en el tratamiento de
Insuficiencia cardiaca (IC) y de ser la principal causa de morbilidad y mortalidad en los …

Abstract Sodium-glucose co-transporter 2 (SGLT2) inhibitors, originally used for diabetes
mellitus, are gaining more popularity for other indications owing to their positive …